Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 791-807, October 2007

Human reporter genes: potential use in clinical studies

  • Inna Serganova

      Affiliations

    • Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
  • ,
  • Vladimir Ponomarev

      Affiliations

    • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
  • ,
  • Ronald Blasberg

      Affiliations

    • Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    • Corresponding Author InformationCorresponding author. Department of Neurology, Memorial Sloan-Kettering Cancer Center, Box 52, 1275 York Avenue, New York, NY 10021, USA. Tel.: +1 646 888 2211; fax: +1 646 422 0408.

Received 23 April 2007; accepted 23 May 2007. published online 10 August 2007.

Abstract 

The clinical application of positron-emission-tomography-based reporter gene imaging will expand over the next several years. The translation of reporter gene imaging technology into clinical applications is the focus of this review, with emphasis on the development and use of human reporter genes. Human reporter genes will play an increasingly more important role in this development, and it is likely that one or more reporter systems (human gene and complimentary radiopharmaceutical) will take leading roles. Three classes of human reporter genes are discussed and compared: receptors, transporters and enzymes. Examples of highly expressed cell membrane receptors include specific membrane somatostatin receptors (hSSTrs). The transporter group includes the sodium iodide symporter (hNIS) and the norepinephrine transporter (hNET). The endogenous enzyme classification includes human mitochondrial thymidine kinase 2 (hTK2). In addition, we also discuss the nonhuman dopamine 2 receptor and two viral reporter genes, the wild-type herpes simplex virus 1 thymidine kinase (HSV1-tk) gene and the HSV1-tk mutant (HSV1-sr39tk). Initial applications of reporter gene imaging in patients will be developed within two different clinical disciplines: (a) gene therapy and (b) adoptive cell-based therapies. These studies will benefit from the availability of efficient human reporter systems that can provide critical monitoring information for adenoviral-based, retroviral-based and lenteviral-based gene therapies, oncolytic bacterial and viral therapies, and adoptive cell-based therapies. Translational applications of noninvasive in vivo reporter gene imaging are likely to include: (a) quantitative monitoring of gene therapy vectors for targeting and transduction efficacy in clinical protocols by imaging the location, extent and duration of transgene expression; (b) monitoring of cell trafficking, targeting, replication and activation in adoptive T-cell and stem/progenitor cell therapies; (c) and assessments of endogenous molecular events using different inducible reporter gene imaging systems.

Keywords: Human reporter genes, PET, Gamma camera, SPECT, Molecular imaging, [124I]MIBG, [124I]FIAU

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(07)00138-2

doi:10.1016/j.nucmedbio.2007.05.009

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 791-807, October 2007